DayStar Technologies Selects InfusionCapital as
Investment Banker
Orlando, Florida, August 7, 2006 – InfusionCapital is
selected by DST to spearhead next round of financing.
“Because of InfusionCapital’s proven track record with
the success of DayStar’s Initial Public Offering in
2004, DayStar chose the company again to select and
manage future underwritters,” states Kelly McCarthy,
President of InfusionCapital.
About DayStar Technologies
DayStar Technologies, Inc.
is an emerging leader in low cost, high efficiency
Photovoltaic Foil™
that converts sunlight into energy. The Company
manufactures CIGS solar cells, which are deposited on
flexible metal foils using production processes adapted
from computer component manufacturing. As an alternative
to wafer-silicon solar cells, DayStar believes the
unique combination of its CIGS solar cell design coupled
with proprietary manufacturing processes on flexible
metal substrates could substantially lower costs and
remove deployment barriers currently limiting large
adoption of solar energy. For more information on the
Company, please visit
www.daystartech.com.
About InfusionCapital
InfusionCapital provides a
uniquely integrated approach to capital formation. They
have the experience and expertise to guide clients
through complex capital formation processes. They
leverage their years of investment banking experience on
Wall Street, and their long term relationships with
leading portfolio management firms, key investment
managers, and national brokerages to help clients make
the right connections and deliver a consistently
powerful message that gets results. For further
information about InfusionCapital, visit
www.infusioncapital.com.
###
For more information,
contact Gina Andrews, Communications
407-566-1010 or by email at
gina@InfusionCapital.com.
